CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS DOI Eşleşti SJR Q1

Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris

Journal of Cosmetic Dermatology · Aralık 2020

Özet
Background: Acne vulgaris is a common skin disease in adolescents known to be associated with oxidative stress. However, the number of studies in which oxidative stress and antioxidants are evaluated together is limited. Aims: In this study, we aimed to investigate L-arginine/nitric oxide (NO) pathway metabolites, ischemia-modified albumin (IMA), and vitamin A and E levels in patients with acne and its association with disease severity. Patients/Methods: Ninety patients with acne and 30 healthy adults were included in the study. The serum levels ofL-arjinin, L-arginine metabolites, IMA, and vitamins A and E measured in the patient and control groups. Results: Asymmetric dimethylarginine (ADMA), LNG-monomethyl-L-arginine (L-NMMA) and symmetric dimethylarginine (SDMA), and IMA levels were significantly higher in the patients with acne than in the control group (P ˂.05). The L-arginine/ADMA ratio and citrulline and vitamin A levels were significantly lower in patients with acne than those of the controls (P ˂.05). ADMA and IMA plasma levels were increased in parallel with the disease severity (P ˂.05). L-arginine/ADMA ratio, L-arginine, citrulline, and vitamin A plasma levels decreased as the disease became severe (P ˂.05). Although L-arginine and vitamin E levels were lower in the patient group compared to the control group, the difference was not statistically significant (P ˃.05). Conclusion: These results suggest that IMA and L-arginine-NO pathway associated with ischemia and oxidative stress may play an important role in the pathogenesis and progression of acne vulgaris.
15 atıf Aralık 2020 DOI
YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. ALİ ÜNLÜ →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. ALİ ÜNLÜ →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. SEDAT ABUŞOĞLU →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. GÜLCAN SAYLAM KURTİPEK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. ALİ ÜNLÜ →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
Journal of Cosmetic Dermatology · 2020 SCI-Expanded
Prof. Dr. ALİ ÜNLÜ →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 11 kaydı bulundu.
Successful treatment of delayed pressure urticaria with 300 mg of omalizumab every 14 days
2021 ISSN: 1473-2130 SCI-Expanded Q3
Prof. Dr. GÜLCAN SAYLAM KURTİPEK →
Granulomatous periorificial dermatitis with a dramatic response methotrexate treatment.
2021 ISSN: 1473-2130 SCI-Expanded
Prof. Dr. GÜLCAN SAYLAM KURTİPEK →
Successful treatment of delayed pressure urticaria with 300 mg of omalizumab every 14 days.
2021 ISSN: 1473-2130 SCI-Expanded
Prof. Dr. GÜLCAN SAYLAM KURTİPEK →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
2020 ISSN: 1473-2130 SCI-Expanded
Prof. Dr. ALİ ÜNLÜ →
Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris
2020 ISSN: 1473-2130 SCI-Expanded Q2
Prof. Dr. ALİ ÜNLÜ →
Granulomatous periorificial dermatitis with a dramatic response methotrexate treatment
2020 ISSN: 1473-2130 SCI-Expanded
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Pyoderma gangrenosum with thymoma and myasthenia gravis: A case report
2021 ISSN: 1473-2130 SCI-Expanded Q3
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Successful treatment of delayed pressure urticaria with 300 mg of omalizumab every 14 days
2021 ISSN: 1473-2130 SCI-Expanded Q3
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Infantile Eosinophilic Pustular Folliculitis: A Case Report
2023 ISSN: 1473-2130 SCI-Expanded Q2
Prof. Dr. GÜLCAN SAYLAM KURTİPEK →
Infantile Eosinophilic Pustular Folliculitis: A Case Report
2022 ISSN: 1473-2130 SCI-Expanded Q2
Doç. Dr. FATMA TUNÇEZ AKYÜREK →
Social media use as a source of information by acne vulgaris patients
2024 ISSN: 1473-2130 SCI-Expanded Q2
Doç. Dr. BAHAR ÜRÜN ÜNAL →

Makale Bilgileri

Toplam Atıf 15 atıf · Scopus
ISSN14732130
Yayın TarihiAralık 2020
Cilt / Sayfa19 · 3408-3413

Kurumlar

Necmettin Erbakan Üniversitesi
Meram Turkey
Selçuk Üniversitesi
Selçuklu Turkey

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 15.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Journal of Cosmetic Dermatology
Q1
SJR Skoru0,834
H-Index75
YayıncıJohn Wiley and Sons Inc
ÜlkeUnited Kingdom
Dermatology (Q1)
Dergi sayfasına git

Metrikler

15
Atıf

Sistemimizdeki Yazarlar